CoChat

A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndrome

Open access

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

PURPOSE: Sodium oxybate (SXB) is approved for cataplexy and excessive daytime sleepiness in narcolepsy. Obstructive sleep apnea syndrome (OSAS) affects ∼9-50% of narcoleptics. Effects of 2-week SXB administration on apnea-hypopnea index (AHI), oxygen saturation (SaO(2)), and sleep architecture were investigated in OSAS patients. METHODS: OSAS patients (n = 48) received 2-week SXB or placebo (PBO) treatment with polysomnography at baseline and day 14. The primary outcome measure was change from baseline in mean AHI. Secondary outcomes included changes from baseline in SaO(2), and sleep architecture. RESULTS: Compared with PBO, SXB significantly increased reduction in mean AHI and obstructive apnea index with SXB (-0.8 ± 13.3 vs. -8.2 ± 10.0; p = 0.0327 and 3.54 ± 11.1 vs. -4.72 ± 7.7; p = 0.0054, respectively) and significantly increased change in slow wave sleep duration (5.2 ± 25.0 min vs. 29.4 ± 37.0 min; p = 0.0038). There were no differences between treatments in SaO2, central apneic events, or other measures. Adverse events, most commonly headache, were noted in nine of 27 (33%) and six of 23 (26%) patients receiving SXB and PBO, respectively. CONCLUSIONS: Short-term use of 4.5 g/night SXB did not generate respiratory depressant effects in OSAS patients as measured by AHI, obstructive apnea events, central apneas, and SaO2. Extended use of SXB in higher therapeutic doses in OSAS has not been studied, and merits caution.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11325-009-0320-0

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Subject flow diagram
Fig. 1 Subject flow diagramCC BY-NC · PubMed Central
Fig. 2 Correlation analysis of SWS and AHI. The change from baseline in SWS was negatively correlated with the change from baseline in AHI for all patients (r = −0.38; p = 0.0074) but not for SXB (r = −0.252, ns) or PBO (r = −0.274, ns) alone
Fig. 2 Correlation analysis of SWS and AHI. The change from baseline in SWS was negatively correlated with the change from baseline in AHI for all patients (r = −0.38; p = 0.0074) but not for SXB (r = −0.252, ns) or PBO (r = −0.274, ns) aloneCC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Research works printed but not linked: 3

  1. Santamaria J, Sansa G, Iranzo A (2007) Prevalence and clinical relevance of sleep apnea in narcolepsy. Sleep 30(Suppl):A224–A225
  2. Black JE, Ristanovic R, Mamelak M, Montplaisir J (2002) Effect of increasing doses of sodium oxybate on nocturnal oxygen saturation: preliminary findings. Sleep 25(Suppl):A474–A475
  3. Ristanovic R, Black J, Mamelak M, Montplaisir J (2002) Analysis of dose effects of sodium oxybate on nocturnal respiratory disturbances. Sleep 25(Suppl):A473–A474

Cited by

See all 40

Metadata

Authors
George, C. F. P., Feldman, N., Zheng, Y., Steininger, T. L., Grzeschik, S. M., Lai, C., & Inhaber, N.
Affiliations
  • Western University (CA)
  • Jazz Pharmaceuticals (United States) (US)
Corresponding author
George, Charles F. P.
Venue
Sleep and Breathing
Published
2010-01-18
Volume
15
Issue
1
Pages
13-20
ISSN
  • 1520-9512 (ISSN-L)
  • 1522-1709
OpenAlex
W2160493529
Cited by
40
References
36
Citations by year
2026: 1 · 2025: 1 · 2024: 5 · 2023: 1 · 2022: 3 · 2021: 2 · 2019: 3 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 3 · 2014: 2 · 2013: 3 · 2012: 2
FWCI
2.60
Type
journal article
Language
en
Open access
Licence
  • cc-by-nc
  • creativecommons.org/licenses/by-nc/2.0 (tdm)
Locations
  • Sleep And Breathing (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • Sanofi
  • Jazz Pharmaceuticals
Topics
  • Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
Keywords
sodium oxybate, obstructive sleep apnea, narcolepsy, apnea-hypopnea index, obstructive apnea, slow-wave sleep, oxygen saturation, central sleep apnea, respiratory depression, drug safety, headache adverse event
MeSH terms
Zolpidem, Modafinil, Adult, Central Nervous System Stimulants, Adjuvants, Anesthesia, Benzhydryl Compounds, Combined Modality Therapy, Drug Therapy, Combination, Female, Humans, Disorders of Excessive Somnolence, Hypnotics and Sedatives, Male, Middle Aged, Pyridines, Sodium Oxybate, Polysomnography, Sleep Apnea, Obstructive, Continuous Positive Airway Pressure

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndrome. https://app.cochat.ai/papers/10.1007/s11325-009-0320-0
The paper
George, C. F. P., Feldman, N., Zheng, Y., Steininger, T. L., Grzeschik, S. M., Lai, C., & Inhaber, N. (2011). A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndrome. Sleep and Breathing. https://doi.org/10.1007/s11325-009-0320-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.